Immune checkpoint inhibitors can produce distinct toxic effects that require prompt recognition and timely management.
To develop a technology-enabled, dynamically adaptive protocol that can provide the accurate information needed to inform specific remedies for immune toxic effects in patients treated with immune checkpoint inhibitors.